Overview Effect of Rifampin on Bosutinib When Both Are Given to Healthy People Status: Completed Trial end date: 2008-08-01 Target enrollment: Participant gender: Summary Study to examine whether rifampin has an effect on the pharmacokinetics of bosutinib. Phase: Phase 1 Details Lead Sponsor: Wyeth is now a wholly owned subsidiary of PfizerTreatments: Rifampin